Courts Should Kill Trump's Pricey '2-for-1' Deregulation Order
Joint Letter to OIRA re Guidance to Agencies on Implementation of 2-for-1 Deregulatory Executive Order
Lisa Heinzerling's testimony before the Senate Commerce Committee on the importance of regulatory safeguards.
Lisa Heinzerling's February 1, 2017, testimony before the Senate Commerce Committee on the importance of regulatory safeguards.
Author(s): Lisa Heinzerling
January 30, 2017, President Trump Calls for Rationing Health and Safety in 'One In, Two Out' Executive Order on Public Protections
Quietly Passed Act Favors Profits Over Health and Safety
December 21, 2016, Likely Regulatory Adviser to Trump Would Further Stack the Deck Against Families and Communities
December 13, 2016, CPR's Klass on Trump Choice of Perry for Energy: American Leadership on Clean Energy Future Is on Indefinite Hold
December 14, 2016, CPR's Glicksman on Trump Choice of Zinke for Interior: Does Nothing to Erase Fears
Beware Compounded Drugs -- Especially Under Trump’s FDA
Writing for The American Prospect, Rena Steinzor observes that a burgeoning and little-regulated private industry that specially mixes drugs at so-called compounding pharmacies poses a public-health hazard that the Trump administration will only make worse.
Author(s): Rena Steinzor